Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New formulation of rhGH from Alkermes and Genentech

July 12, 1996

KGR-1380: A novel glycation inhibitor

July 12, 1996

Aldose reductase inhibitors described by Grelan

July 12, 1996

Optro enters U.S./Canadian phase II trials

July 12, 1996

Pharmacia & Upjohn terminates Hemopure codevelopment agreement

July 12, 1996

Results of fat accumulation/PAI-1 levels relationship study disclosed

July 12, 1996

Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb

July 12, 1996

(+)-Sch-58053: Schering-Plough's cholesterol absorption inhibitor

July 12, 1996

Pfizer and Warner-Lambert sign atorvastatin agreement

July 12, 1996

Cathepsin B and L inhibitors in Fujisawa's pipeline

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...